The influence of oncometabolites on this repair process was discovered because many of the brain tumor patients with a methylated MGMT promoter in tumor cells were IDH mutants [220,221,222], and they showed the best response to chemotherapy with alkylating agents [223,224,225,226,227]. The gene discussed is IDH2; the disease is brain neoplasm.